CompoAtlas

UltraFlora® BiomePro Probiotic

Natural health product licensed in Canada

Licence holder
Metagenics Inc.
NPN or DIN-HM
80105903
Status
Active licence
Licence date
5 November 2020
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Lactobacillus rhamnosus

Source : HN001

5 Milliards d'UFCNot calculated
Lactobacillus rhamnosus

Source : Cellule entière

5 Milliards d'UFCNot calculated
Bifidobacterium animalis subsp. lactis

Source : BL-04

20 Milliards d'UFCNot calculated
Bifidobacterium animalis subsp. lactis

Source : Cellule entière

20 Milliards d'UFCNot calculated
Lacticaseibacillus rhamnosus

Source : GG

20 Milliards d'UFCNot calculated
Lacticaseibacillus rhamnosus

Source : Cellule entière

20 Milliards d'UFCNot calculated
Lactobacillus acidophilus

Source : NCFM

12.5 Milliards d'UFCNot calculated
Lactobacillus acidophilus

Source : Cellule entière

12.5 Milliards d'UFCNot calculated
Bifidobacterium animalis subsp. lactis

Source : Cellule entière

5 Milliards d'UFCNot calculated
Bifidobacterium animalis subsp. lactis

Source : HN019

5 Milliards d'UFCNot calculated
Lacticaseibacillus paracasei

Source : Cellule entière

10 Milliards d'UFCNot calculated
Lacticaseibacillus paracasei

Source : LPC-37

10 Milliards d'UFCNot calculated

Non-medicinal ingredients

Cellulose microcristalline, Sucrose, Hydroxypropyl méthylcellulose, Stéarate de magnésium, Silice

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Capsule1 Tous les jours

Uses authorised in Canada

Features Lactobacillus rhamnosus GG to help support gastrointestinal health. Features the clinically-effective doses of a combination of Lactobacillus acidophilus NCFM, Bifidobacterium lactis Bi-07, Lactobacillus paracasei Lpc-37 and Bifidobacterium lactis Bl-04 shown to support a healthy intestinal microbiome. Features the clinically effective dose of Bifidobacterium lactis HN019 that may help support healthy gastrointestinal motility. Features probiotics that have been shown to help support a healthy intestinal environment Could promote a favorable gut flora. Helps support intestinal/gastrointestinal health. Helps to manage acute infectious diarrhoea. Helps to manage and/or reduce the risk of antibiotic-associated diarrhoea. Source of Probiotics.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80105903

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line